1. Home
  2. ACRV vs PCQ Comparison

ACRV vs PCQ Comparison

Compare ACRV & PCQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACRV
  • PCQ
  • Stock Information
  • Founded
  • ACRV 2018
  • PCQ 2001
  • Country
  • ACRV United States
  • PCQ United States
  • Employees
  • ACRV N/A
  • PCQ N/A
  • Industry
  • ACRV Medicinal Chemicals and Botanical Products
  • PCQ Investment Managers
  • Sector
  • ACRV Health Care
  • PCQ Finance
  • Exchange
  • ACRV Nasdaq
  • PCQ Nasdaq
  • Market Cap
  • ACRV 225.8M
  • PCQ 188.5M
  • IPO Year
  • ACRV 2022
  • PCQ N/A
  • Fundamental
  • Price
  • ACRV $7.87
  • PCQ $10.01
  • Analyst Decision
  • ACRV Strong Buy
  • PCQ
  • Analyst Count
  • ACRV 5
  • PCQ 0
  • Target Price
  • ACRV $22.60
  • PCQ N/A
  • AVG Volume (30 Days)
  • ACRV 103.0K
  • PCQ 69.6K
  • Earning Date
  • ACRV 11-07-2024
  • PCQ 01-01-0001
  • Dividend Yield
  • ACRV N/A
  • PCQ 4.63%
  • EPS Growth
  • ACRV N/A
  • PCQ N/A
  • EPS
  • ACRV N/A
  • PCQ N/A
  • Revenue
  • ACRV N/A
  • PCQ N/A
  • Revenue This Year
  • ACRV N/A
  • PCQ N/A
  • Revenue Next Year
  • ACRV N/A
  • PCQ N/A
  • P/E Ratio
  • ACRV N/A
  • PCQ N/A
  • Revenue Growth
  • ACRV N/A
  • PCQ N/A
  • 52 Week Low
  • ACRV $3.19
  • PCQ $8.19
  • 52 Week High
  • ACRV $11.90
  • PCQ $10.50
  • Technical
  • Relative Strength Index (RSI)
  • ACRV 57.76
  • PCQ 57.89
  • Support Level
  • ACRV $6.87
  • PCQ $9.88
  • Resistance Level
  • ACRV $8.16
  • PCQ $9.99
  • Average True Range (ATR)
  • ACRV 0.33
  • PCQ 0.10
  • MACD
  • ACRV 0.13
  • PCQ -0.03
  • Stochastic Oscillator
  • ACRV 77.86
  • PCQ 36.11

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

About PCQ PIMCO California Municipal Income Fund

PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal and California income tax. The fund makes investments in different sectors such as healthcare, property, education, Natural Gas, and others.

Share on Social Networks: